ABCC1 and non-small cell lung carcinoma: MRP1 overexpression is related to drug resistance in acute myeloblastic, glioma, lymphoblastic leukemia, head and neck cancer, NSCLC, neuroblastoma, melanoma, prostate, breast, kidney, and thyroid cancer [111].